Fig. 2From: Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanomaModel structure. *PFS = progression-free survival; PD = progressive disease; AEs = adverse eventsBack to article page